or Login to see your representatives.

Access Candidates' and Representatives' Biographies, Voting Records, Interest Group Ratings, Issue Positions, Public Statements, and Campaign Finances

Simply enter your zip code above to get to all of your candidates and representatives, or enter a name. Then, just click on the person you are interested in, and you can navigate to the categories of information we track for them.

Public Statements

Senator Max S. Baucus's Public Statements on Drugs

Full Name: Max S. Baucus
Office: U.S. Senate (MT) - Sr, Democratic
First Elected: 11/07/1978
Last Elected: 11/04/2008
Next Election: 2014
Gender: Male
Family: Wife: Wanda Minge; 1 Child: Zeno
Birth Date: 12/11/1941
Birth Place: Helena, MT
Home City: Missoula, MT
Religion: United Church of Christ
Date Title Location
May 9, 2012 Grassley, Baucus Seek Answers About Opioid Manufacturers' Ties to Medical Groups Washington, DC
May 8, 2012 Baucus, Grassley Seek Answers about Opioid Manufacturers' Ties to Medical Groups Washington, DC
March 23, 2012 Baucus Applauds Health Reform's Record of Cutting Costs for Consumers, Taxpayers Washington, DC
Dec. 7, 2011 Hearing of the Senate Finance Committee - Baucus Statement on Drug Shortages Unknown
Dec. 7, 2011 Baucus Calls Hearing to Examine National Drug Shortage Crisis Hurting Montana Patients Washington, DC
Dec. 1, 2011 Letter to Ian Read, President and Chief Executive Officer Pfizer Inc. Unknown
Nov. 30, 2011 Letter to David T. Blair, Chief Executive Officer Catalyst Rx Washington, DC
Oct. 18, 2011 Agricultural, Rural Development, Food and Drug Administration, And Related Agencies Appropriations Act of 2012 Washington, DC
Aug. 4, 2011 Baucus: Health Reform Reducing Costs for Seniors, Increasing Benefits Washington, DC
May 25, 2011 Baucus, Grassley Report Details Financial Relationship Between Drug Company, Physicians Who Lobbied the FDA Washington, DC
Feb. 2, 2011 FAA Air Transportation Modernization and Safety Improvement Act Washington, DC
Nov. 30, 2010 Baucus & Bingaman: GAO Report Charts Path to Enhance Crackdown on Drug Cartel Profits Washington, DC
June 8, 2010 American Jobs and Closing Tax Loopholes Act of 2010 Washington, DC
March 24, 2010 Health Care and Education Reconciliation Act of 2010 Washington, DC
Dec. 15, 2009 Service Members Home Ownership Tax Act Of 2009--Resumed Washington, DC
Dec. 3, 2009 Service Members Home Ownership Tax Act Of 2009 Washington, DC
Dec. 1, 2009 The Patient Protection And Affordable Care Act Unknown
Dec. 1, 2009 Service Members Home Ownership Tax Act Of 2009--Resumed Washington, DC
June 20, 2009 Baucus, Pharmaceutical Companies Announce Deal to Reduce Prescription Drug Costs for Seniors Washington, DC
April 2, 2009 Hearing of the Senate Finance Committee - The Nomination of Governor Kathleen Sebelius (D-KS) to be Secretary of Health and Human Services Washington, DC
March 10, 2009 Hearing of the Senate Finance Committee - The President's Fiscal Year 2010 Health Care Proposals Washington, DC
March 5, 2009 Omnibus Appropriations Act, 2009 Washington, DC
Feb. 25, 2009 Hearing of the Senate Committee on Finance - "Scoring Health Care Reform: CBO's Budget Options Washington, DC
Feb. 13, 2009 Statements on Introduced Bills and Joint Resolutions Washington, DC
Oct. 2, 2008 Senate Resolution 703--Designating November 2008 as "National Methamphetamine Awareness Month", to Increase Awareness of Methamphetamine Abuse Washington, DC
Sept. 4, 2008 HHS Inspector General's Report on Marketing Materials for Prescription Drug Plans Washington, DC
June 11, 2008 New CMS Rule on Medicare Data-sharing Washington, DC
April 22, 2008 High Intensity Drug Trafficking Areas Should Get More Funding Washington, DC
April 7, 2008 Letter to Robert Byrd and Thad Cochran, Chairman and Ranking Member of the Senate Committee on Appropriations, Re: JAG Funding Washington, DC
March 31, 2008 Letter to Robert Byrd and Thad Cochran, Chairman and Ranking Member of the Senate Committee on Appropriations, Re: Restore Byrne/JAG Grants for State and Local Law Enforcement in Supplemental Appropriations Bill Washington, DC
Feb. 21, 2008 Finance Leaders Aim to Help Seniors Seeking Addional Coverage From Medicare Drug Benefit Plans Washington, DC
Feb. 14, 2008 Remarks of Senator Max Baucus Before the AARP's Board of Directors Washington, DC
Jan. 11, 2008 Baucus, Grassley Comment on Report on Medicare Drug Benefit Payments to Community Pharmacies Washington, DC
Dec. 20, 2007 Finance Leaders Demand CMS Fix Serious and Systemic Contracting Deficiencies That Led tio Millions in Questionable Payments Washington, DC
Dec. 14, 2007 Baucus Launches Inquiry after Mitchell Report, Seeking Steroid-Related Tax, Trade Violations Washington, DC
Dec. 14, 2007 Letter to Senator George J. Mitchell, Re: Steroid-Related Tax, Trade Violations Washington, DC
Nov. 20, 2007 Letter to Dr. Tadataka Yamada, Global Health Program President, Bill and Melinda Gates Foundation, Re: GlaxoSmithKline Drug Company Intimidation Case Washington, DC
Nov. 15, 2007 Making Emergency Supplemental Appropriations Motion to Proceed Washington, DC
Nov. 15, 2007 Statement Regarding the Finance Committee Investigation of Avandia unknown
Oct. 1, 2007 Letter to Administrator of Centers for Medicare and Medicaid Service Re: Increased Oversight of Marketing Washington, DC
Oct. 1, 2007 Senators Continue Robust Oversight of Medicare Drug Benefit Washington, DC
Sept. 20, 2007 Foor and Drug Administration Amendments Act of 2007 Washington, DC
Sept. 18, 2007 Hearing of the Senate Finance Committee on Methamphetamine Supply Chain Disruption Washington, DC
Aug. 2, 2007 Baucus Bill Will Bring Fair Deal to American Pharmacies Washington, DC
Aug. 2, 2007 Statements on Introduced Bills and Joint Resolutions Washington, DC
Aug. 2, 2007 Senators Introduce Bill to Improve Medicare Drug Benefit Access and to Help Pharmacies Better Serve Beneficiaries Washington, DC
July 24, 2007 Letter to The Honorable Andrew C. von Eschenbach, M.D., Commissioner, U.S. Food and Drug Administration Washington, DC
June 21, 2007 Finance Leaders: GAO Shows Medicare Drug Benefit Could Serve Low-Income Seniors Better Washington, DC
June 11, 2007 Letter to The Honorable Andrew C. von Eschenbach, M.D., Commissioner, Food and Drug Administration, Department of Health and Human Services Washington, DC
May 21, 2007 Letter to the FDA and Letter to GlaxoSmithKline Washington, DC
Back to top